Avista Capital Partners has announced it has closed its fifth fund with $1.2 billion.
The fund was over-subscribed, hit its hard-cap and exceeded its target of $775 million.
Avista Capital Partners, based in New York, is a healthcare-focused private equity firm that makes control buyout investments in the middle market. Founded in 2005, the firm pursues investments in medical devices and technologies, pharmaceuticals, outsourced pharmaceutical services, healthcare technology, healthcare distribution and consumer-driven healthcare sectors.
The new fund is comprised of public pension funds, university endowments and foundations, family offices, insurance companies and asset managers across North America, Europe, Asia and the Middle East.